EPG Wealth Management’s Boston Scientific BSX Stock Holding History

EPG Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,422	Closed	-$1.22M	–	321
2026 Q1	$1.22M	Buy	19,422 +1,445	+8%	+$116K	0.33%	77
2025 Q4	$1.71M	Buy	17,977 +445	+3%	+$43.6K	0.46%	59
2025 Q3	$1.71M	Buy	17,532 +494	+3%	+$51.2K	0.47%	59
2025 Q2	$1.83M	Buy	17,038 +814	+5%	+$82.4K	0.55%	46
2025 Q1	$1.64M	Buy	16,224 +574	+4%	+$57.8K	0.46%	57
2024 Q4	$1.4M	Sell	15,650 -649	-4%	-$57.1K	0.37%	73
2024 Q3	$1.37M	Buy	+16,299	New	+$1.28M	0.34%	80
2024 Q2	–	Sell	-17,110	Closed	-$1.25M	–	83
2024 Q1	$1.17M	Buy	17,110 +170	+1%	+$10.9K	0.29%	92
2023 Q4	$1.1M	Buy	16,940 +411	+2%	+$21.9K	0.29%	91
2023 Q3	$873K	Buy	+16,529	New	+$867K	0.26%	95

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EPG Wealth Management's BSX Position: Q2 2026 in Review

EPG Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 19,422 shares — an estimated $1.22M sold.

EPG Wealth Management first reported a position in BSX in Q3 2023 and held it in 10 quarters. The position peaked at $1.83M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

EPG Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
EPG Wealth Management sold 19,422 Boston Scientific shares in Q2 2026, an estimated $1.22M.
EPG Wealth Management first reported a position in Boston Scientific in Q3 2023 and held it in 10 quarters.
EPG Wealth Management's Boston Scientific position peaked at $1.83M in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on EPG Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.